These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1550252)
1. Mixtures of synthetic peptides and dipalmitoylphosphatidylcholine as lung surfactants. McLean LR; Krstenansky JL; Jackson RL; Hagaman KA; Olsen KA; Lewis JE Am J Physiol; 1992 Mar; 262(3 Pt 1):L292-300. PubMed ID: 1550252 [TBL] [Abstract][Full Text] [Related]
2. An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant. McLean LR; Lewis JE; Krstenansky JL; Hagaman KA; Cope AS; Olsen KF; Matthews ER; Uhrhammer DC; Owen TJ; Payne MH Am Rev Respir Dis; 1993 Feb; 147(2):462-5. PubMed ID: 8430972 [TBL] [Abstract][Full Text] [Related]
3. Amphipathic alpha-helical peptides based on surfactant apoprotein SP-A. McLean LR; Lewis JE; Hagaman KA; Owen TJ; Jackson RL Biochim Biophys Acta; 1993 Feb; 1166(1):31-8. PubMed ID: 8431490 [TBL] [Abstract][Full Text] [Related]
4. Role of the hydrophobic face of amphipathic alpha-helical peptides in synthetic pulmonary surfactants. McLean LR; Lewis JE; Hagaman KA; Owen TJ; Matthews ER J Pharmacol Exp Ther; 1993 Aug; 266(2):551-6. PubMed ID: 8355190 [TBL] [Abstract][Full Text] [Related]
5. Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution. Nilsson G; Gustafsson M; Vandenbussche G; Veldhuizen E; Griffiths WJ; Sjövall J; Haagsman HP; Ruysschaert JM; Robertson B; Curstedt T; Johansson J Eur J Biochem; 1998 Jul; 255(1):116-24. PubMed ID: 9692909 [TBL] [Abstract][Full Text] [Related]
6. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Revak SD; Merritt TA; Hallman M; Heldt G; La Polla RJ; Hoey K; Houghten RA; Cochrane CG Pediatr Res; 1991 May; 29(5):460-5. PubMed ID: 1896249 [TBL] [Abstract][Full Text] [Related]
7. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593 [TBL] [Abstract][Full Text] [Related]
8. Protein composition of synthetic surfactant affects gas exchange in surfactant-deficient rats. Walther FJ; Hernández-Juviel J; Bruni R; Waring AJ Pediatr Res; 1998 May; 43(5):666-73. PubMed ID: 9585014 [TBL] [Abstract][Full Text] [Related]
9. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs. Wang Z; Chang Y; Schwan AL; Notter RH Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674 [TBL] [Abstract][Full Text] [Related]
10. Improvement of pulmonary surfactant activity by introducing D-amino acids into highly hydrophobic amphiphilic α-peptide Hel 13-5. Nakamura Y; Yukitake K; Nakahara H; Lee S; Shibata O; Lee S Biochim Biophys Acta; 2014 Aug; 1838(8):2046-52. PubMed ID: 24796503 [TBL] [Abstract][Full Text] [Related]
11. The role of charged amphipathic helices in the structure and function of surfactant protein B. Waring AJ; Walther FJ; Gordon LM; Hernandez-Juviel JM; Hong T; Sherman MA; Alonso C; Alig T; Braun A; Bacon D; Zasadzinski JA J Pept Res; 2005 Dec; 66(6):364-74. PubMed ID: 16316452 [TBL] [Abstract][Full Text] [Related]
12. Surfactant protein B: lipid interactions of synthetic peptides representing the amino-terminal amphipathic domain. Bruni R; Taeusch HW; Waring AJ Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7451-5. PubMed ID: 1871144 [TBL] [Abstract][Full Text] [Related]
13. Mixtures of low molecular weight surfactant proteins and dipalmitoyl phosphatidylcholine duplicate effects of pulmonary surfactant in vitro and in vivo. Smith GB; Taeusch HW; Phelps DS; Keough KM Pediatr Res; 1988 May; 23(5):484-90. PubMed ID: 3387170 [TBL] [Abstract][Full Text] [Related]